Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer.

Abstract

BACKGROUND 5-Fluorouracil and leucovorin plus oxaliplatin (FOLFOX) or capecitabine plus oxaliplatin (XELOX) is a standard adjuvant treatment for patients with stage III colon cancer (CC). Capecitabine is an oral fluoropyrimidine, and administration of oxaliplatin does not necessarily require the insertion of a central venous access device (CVAD). We… (More)
DOI: 10.1016/j.clcc.2015.11.004

Topics

3 Figures and Tables

Cite this paper

@article{LapeyreProst2016FeasibilityOC, title={Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer.}, author={Alexandra Lapeyre-Prost and Marine Hug de Larauze and Benoist Chibaudel and Marie Line Garcia and Veronique Guering-Meyer and Olivier Bouch{\'e} and Eveline J Boucher and Marc Ychou and J{\'e}r{\^o}me Dauba and St{\'e}phane Obled and Astrid Li{\`e}vre and David Malka and Roger Faroux and Isabelle Bonnet and Julien Taieb and Thierry Andr{\'e}}, journal={Clinical colorectal cancer}, year={2016}, volume={15 3}, pages={250-6} }